ketotifen has been researched along with Extravascular Hemolysis in 1 studies
Ketotifen: A cycloheptathiophene blocker of histamine H1 receptors and release of inflammatory mediators. It has been proposed for the treatment of asthma, rhinitis, skin allergies, and anaphylaxis.
ketotifen : An organic heterotricyclic compound that is 4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one which is substituted at position 4 by a 1-methylpiperidin-4-ylidene group. A blocker of histamine H1 receptors with a stabilising action on mast cells, it is used (usually as its hydrogen fumarate salt) for the treatment of asthma, where it may take several weeks to exert its full effect.
Excerpt | Relevance | Reference |
---|---|---|
"Ketotifen is an older molecule that possesses antihistaminic activity and is reported to have additional pharmacological properties." | 1.31 | A comparison of the effects of olopatadine and ketotifen on model membranes. ( Brockman, H; Graff, G; Spellman, J; Yanni, J, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brockman, H | 1 |
Graff, G | 1 |
Spellman, J | 1 |
Yanni, J | 1 |
1 other study available for ketotifen and Extravascular Hemolysis
Article | Year |
---|---|
A comparison of the effects of olopatadine and ketotifen on model membranes.
Topics: Animals; Cattle; Cell Membrane Permeability; Dibenzoxepins; Dose-Response Relationship, Drug; Drug I | 2000 |